• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Boel Akupunktur Klinik | Den bedste Akupunktør

Boel Akupunktur Klinik | Den bedste Akupunktør

No. 1 i Akupunkturbehandling

  • Boel Akupunktur
    • Who are we?
    • My dream for Boel Acupuncture
    • Hotel or guest house
    • Courses
  • Eye Diseases
    • ARMD – Macula degeneration
      • Research into ARMD (Age Related Macular Degeneration)
      • Two weeks better than one
      • Newspapers and Magazines
      • Eye specialists experiences with acupuncture treatment
      • Does the improvement last
      • Age Related Macular Degeneration
      • The Press
        • Popular scientific magazines
        • Articles in the technical journals
        • Norwegian acupuncturist magazine
        • The German Press
        • The Norwegian Press
        • The Danish press
      • The history behind the eye acupuncture
      • What do the patients say
      • Medical Doctor with ARMD
      • Early ARMD research
      • German doctors about eye-acupuncture
      • What is the cost of the treatment
      • Scientific research at the university
      • Physician suffering from ARMD
      • What an ARMD patient see
      • Are there any side effects?
    • Diabetic Retinopathy
    • Glaucoma
    • Retinitis Pigmentosa
      • Retinitis Pigmentosa Research
    • German Television Programme
    • Photo of the articles
  • Treatment of Pain
    • Arthritis
  • Other diseases
    • Atherosclerosis
  • Testimonials
  • Needle Shop
  • Contact
  • Dansk
  • Deutsch
  • Norsk Bokmål
  • Svenska
  • ARMD – Macula degeneration

    Research into ARMD (Age Related Macular Degeneration)

    What do you do, when you have a piece of news that you are dying to tell others about?

    What do you do with a piece of world news, which may dramatically affect an increasing population of blind people in the Western world?

    Personally, I am ready to shout it from the rooftops!!

    Instead I have chosen a quieter more direct approach.

    It is simply a method, which can help elderly people afflicted with Aged Related Macular Degeneration (ARMD), which is the most common cause of clinical blindness in the Western world. In Denmark alone, almost 15.000 people are afflicted with this slowly progressing eye-disease every year.

    Surprising Results with acupuncture treatments for Age-related Macular Degeneration

    We have just finished a pilot project with 27 patients suffering from age-related macular degeneration, who were divided into three groups. Their own eye-specialist diagnosed each of the patients as suffering from dry macular degeneration.

    The patients received intensive treatment over the course of four weeks – with the use of a new method of acupuncture called AcuNova or Acupuncture 2000 (not to be compared to Chinese Acupuncture).

    Each of the three groups was treated with a variation of AcuNova. See below for a description of methods involved.

    Each patient’s faculty of vision was measured on the sight board several times over the course of the treatment.

    The results were evaluated after 4 weeks, and as we had expected, the results varied between the three groups. Follow-up evaluations are scheduled after 6 months and a year.

    In test group number three, 60% of the patients experienced a 15,6% improvement in sight. In test group number two, 70% of the patients experienced a 28,5% improvement in sight, and finally in test group number one, 80% of the patients experienced an improvement of 15-40% in sight. The average rate of improvement in sight for all groups was 27%.

    The results of our test document the fact that it is unlikely to cure patients suffering from age-related macular degeneration, but through intensive treatment involving Acupuncture 2000 there is high rate of success for improving the sight of a great deal of our patients.

    Due to our project-results, future treatment of age-related macular degeneration patients will involve similar acupuncture treatments as used in our testing with group number one.

    Experience from our own and other colleague’s clinics have shown a direct relationship between results with age-related macular degeneration patients and results with other patients suffering from eye-diseases.

    Method

    All test patients were applicants for our study as announced in the daily press. 30 applicants were chosen for the study. Each of the applicants was accompanied by a journal from their personal eye-specialist. The study group of 30 was further divided into 3 groups. After careful examination of material it was later discovered that 3 of the patients were not suffering from age-related macular degeneration and the group was therefore reduced to 27 patients. The groups were formed with the following numbers; Group 1: 10 patients, Group 2: 9 patients, and Group 3: 8 patients.

    Variables, for each of the three groups in the pilot project, were method and the number of stimulation points in the body employed during treatment. Each patient received a minimum of two treatments a day for the first 2 weeks (except during the weekend, which was considered a rest period). The following two weeks they received two treatments a week. Each patient received a total of 30 treatments. 

    The treatment results were measured at intervals of one week, with the first control after one week of treatment and the last control after 4 weeks. The control method was the same as the initial test of visual impairment, which was measured using standard sight boards. Each of the patients underwent this test before starting the treatments. In order to eliminate test-uncertainties due to unknown factors, it was decided that improvement of sight was to be measured when an improvement was > a minimum of 15% improvement of sight. As an example: Patient X had 10% vision at the onset of treatment – after 4 weeks of treatment his sight was 50%. For test purposes we considered his improvement to be 40% improvement in sight.

    In test group number three, 60% of the patients experienced a 15,6% improvement in sight. In test group number two, 70% of the patients experienced a 28,5% improvement in sight and finally in test group number one, 80% of the patients experienced an improvement of 15-40% in sight. The average rate of improvement of sight for all groups was 27%. Remarkable for group number one was the fact that we employed the least number of stimulation points in the body. During the first week of treatment the patients were stimulated with 4 needles, while during the final weeks of treatment, the patients were stimulated with 6 needles. The conclusions from our pilot study have led us to employ the method used for group number one as our standard method of treatment.

    Our earlier treatment involved intensive daily treatment over a period of 1 week, so it was exciting to see, that two weeks of intensive treatment gave such dramatic improvements in results.

    Below you can see a short video of one of our patients with dry macular degeneration telling how AcuNova acupuncture at Boel Acupuncture helped his vision.

    Primary Sidebar

    Search our website

    Helene Eskildsen

    Let us help you

    Contact us today for a personal consultation.

    Contact Us Now

    Footer

    Kontakt os

    Tidsbestilling +45 97 87 58 00
    Træffetid kl. 08:30 – 16:00

    København
    Odense
    Århus
    Aulum
    Aalborg
    Esbjerg
    Haslev

    Contact us

    Time reservation +45 97 87 58 00
    Contact hours 08:30 – 16:00

    Søg på hjemmesiden

    Social media

    Follow us on social media

    Copyright © 2025 · Boel Akupunktur ApS. Alle rettigheder forbeholdes. Manage consent.

    • Tel: +45/9787 5800

    • info@boel-akupunktur.dk

    Få vores nyhedsbrev

    Udfyld din e-mail og få tips og viden.

    You decide over your data
    Press "Accept" to accept the digital cookies.

    You can select your preferences on cookies by pressing the "Cookie settings" button.

    Accept Reject Cookie Settings Read More
    Manage consent

    Privacy overview

    This website uses cookies to improve your experience while navigating through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

    CookieDurationDescription
    __cfduid1 monthThe cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
    cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-advertisement1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

    Functional

    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

    CookieDurationDescription
    pll_language1 yearThis cookie is set by Polylang plugin for WordPress powered websites. The cookie stores the language code of the last browsed page.

    Performance

    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

    CookieDurationDescription
    _gat1 minuteThis cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
    YSCsessionThis cookies is set by Youtube and is used to track the views of embedded videos.

    Analytics

    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

    CookieDurationDescription
    _ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
    _gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
    GPS30 minutesThis cookie is set by Youtube and registers a unique ID for tracking users based on their geographical location

    Advertisement

    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

    CookieDurationDescription
    IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
    test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
    VISITOR_INFO1_LIVE5 months 27 daysThis cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.

    Others

    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

    CookieDurationDescription
    CONSENT16 years 9 months 5 days 10 hoursNo description

    Save & Accept
    Powered by